Trends in the global antibiotics market | Nature
CEID Faculty Kevin Outterson co-authors a study on the antibiotics market. See more here.
The struggle to contain the global threat of superbugs | Axios
CEID Faculty Dr. Kevin Outterson says, “We’ve spent untold billions of dollars doing great work knocking back the AIDS pandemic and reducing malaria around the world… We’re not treating bacterial illnesses with the same seriousness that requires governments to see the threat and act like adults.” See more here.
Partnership to Fight Infectious Disease Launches European Chapter | Yahoo!
CEID Faculty Dr. Kevin Outterson is an advisory board member of the Partnership to Fight Infectious Disease, to help “explore and advance solutions to combat the growing threat of antimicrobial resistance.” See more here.
Can We Prevent Antibiotic Resistance? | The Brink
CEID Faculty Dr. Kevin Outterson weighs in on the importance of combatting Antimicrobial Resistance: ‘Antibiotics are unlike other medicines. As bacteria evolve to become resistant, the problem keeps getting worse…We have to run faster, just to avoid falling behind.’ “For Outterson, the work is personal. When his granddaughter was born, the family’s initial joy was […]
Antimicrobial Resistance: What’s At Stake And What Are We Doing About It? | Health Affairs
CEID Faculty Dr. Kevin Outterson and co-authors offer insights about Antimicrobial Resistance (AMR), concluding that: “The antibacterial market is broken. More than a decade of incremental reforms has been helpful, but serious problems remain. Policy makers now have the opportunity to fundamentally reform the sector through delinked pull incentives such as the subscription program in […]
In the calm before the superbug storm, the world needs to prepare
CEID Faculty Kevin Outterson writes in Stat, “the United States and other countries are planning for failure when it comes to preparing for the next public health crises, one of which will certainly be antimicrobial resistance.” Read more here.